Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 11/20 | 0.55 |
| ▸ | RARA | P10276 | 2/20 | 0.47 |
| ▸ | RARG | P13631 | 1/20 | 0.47 |
| ▸ | THRA | P10827 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12437027 | 1.00 | RARB (0.55) | RARBRARARARGTHRATHRB | |
| SCHEMBL4185231 | 0.89 | SMN1; SMN2 (0.48) | RARBALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL13657327 | 0.88 | THRA (0.58) | RARBRARATHRATHRBALDH1A1 | |
| SCHEMBL51732 | 0.84 | THRA (0.61) | RARBRARATHRATHRBALDH1A1 | |
| SCHEMBL2914899 | 0.84 | ALDH1A1 (0.49) | RARBTHRATHRBALDH1A1TSHR | |
| SCHEMBL16810689 | 0.84 | ALDH1A1 (0.51) | ALDH1A1TSHRMAPK1SMN1; SMN2MEN1 | |
| SCHEMBL2910489 | 0.82 | RARB (0.65) | RARBRARARARGTHRATHRB | |
| SCHEMBL13175602 | 0.81 | RARB (0.64) | RARBRARARARGTHRATHRB | |
| SCHEMBL2915987 | 0.80 | ALDH1A1 (0.49) | RARBRARATHRATHRBALDH1A1 | |
| SCHEMBL9230278 | 0.78 | RARB (0.71) | RARBRARARARGTHRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230168538-A1 | OPTICAL ELEMENT AND LIGHT GUIDE ELEMENT | FUJIFILM CORPORATION (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230168538-A1 | OPTICAL ELEMENT AND LIGHT GUIDE ELEMENT | FUJIFILM CORPORATION (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230161199-A1 | OPTICAL ELEMENT AND REFLECTIVE SHEET | FUJIFILM CORPORATION (JP) | 2023-05-25 | — | — | US | disclosed |
| US-20230161199-A1 | OPTICAL ELEMENT AND REFLECTIVE SHEET | FUJIFILM CORPORATION (JP) | 2023-05-25 | — | — | US | disclosed |
| US-20230141025-A1 | SENSOR AND BAND PASS FILTER | FUJIFILM CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230141025-A1 | SENSOR AND BAND PASS FILTER | FUJIFILM CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20220066030-A1 | SENSOR | FUJIFILM CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| US-20220066264-A1 | OPTICAL ELEMENT, WAVELENGTH SELECTIVE FILTER, AND SENSOR | FUJIFILM CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| US-8455563-B2 | Reactive mesogenic compounds and mixtures | MERCK PATENT GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-8451420-B2 | Process of producing substrate for liquid crystal display device, substrate for liquid crystal display device, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20080220246-A1 | Optical Compensation Sheet, Process for Producing the Same, and Polarizing Plate and Liquid Crystal Display Device Using the Same | FUJIFILM CORPORATION (JP) | 2008-09-11 | — | — | US | disclosed |
| EP-1786887-B1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL | MERCK PATENT GMBH (DE) | 2008-07-02 | — | — | EP | disclosed |
| US-20080143943-A1 | Polymerisable Liquid Crystal Material | MERCK PATENT GMBH (DE) | 2008-06-19 | — | — | US | disclosed |
| US-20080055521-A1 | METHOD OF PRODUCING OPTICAL FILM, OPTICAL FILM, POLARIZER PLATE, TRANSFER MATERIAL, LIQUID CRYSTAL DISPLAY DEVICE, AND POLARIZED ULTRAVIOLET EXPOSURE APPARATUS | FUJIFILM CORPORATION (JP) | 2008-03-06 | — | — | US | disclosed |
| US-20080055521-A1 | METHOD OF PRODUCING OPTICAL FILM, OPTICAL FILM, POLARIZER PLATE, TRANSFER MATERIAL, LIQUID CRYSTAL DISPLAY DEVICE, AND POLARIZED ULTRAVIOLET EXPOSURE APPARATUS | FUJIFILM CORPORATION (JP) | 2008-03-06 | — | — | US | disclosed |
| WO-2007089040-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND COLOR FILM PLATE, AND PROCESSES FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007032562-A1 | PROCESS FOR PRODUCING A LIQUID CRYSTAL CELL SUBSTRATE HAVING A TFT DRIVER ELEMENT, A LIQUID CRYSTAL CELL SUBSTRATE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-03-22 | — | — | WO | disclosed |
| WO-2007029885-A1 | TRANSFER MATERIAL, PROCESS FOR PRODUCING A COLOR FILTER USING THE SAME, A COLOR FILTER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007026907-A1 | TRANSFER MATERIAL, PROCESS FOR PRODUCING A LAMINATED STRUCTURE HAVING A PATTERNED OPTICALLY ANISOTROPIC LAYER AND PHOTOSENSITIVE POLYMER LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-03-08 | — | — | WO | disclosed |
| EP-1388538-A1 | Polymerisation Initiator | MERCK PATENT GmbH (DE) | 2004-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080143943-A1 | Polymerisable Liquid Crystal Material | VCL, LCT, LCP1 | RARB 3917/4885RARA 3100/4885RARG 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.